Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
Clinical trial NCT00805766 · COMPLETED
Trial details
- NCT number
- NCT00805766
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.